Clinical Trial Update: A Study of RAY1225 in Participants With Impaired Kidney Function [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating RAY1225 in participants with kidney impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Impairment

Drugs mentioned

• RAY1225

Snippet

Sponsor: Guangdong Raynovent Biotech Co., Ltd | Conditions: Kidney Impairment | Phase 1 | Status: COMPLETED